Postoperative hepatitis - Biotech, Pharma and Life Science Channel

05:05 EST 19th December 2014 | BioPortfolio

PubMed Articles [3706 Associated PubMed Articles listed on BioPortfolio]

Successful treatment of rectovaginal fistula complicating ulcerative colitis with infliximab: a case report and review of the literature.

Rectovaginal fistula is a rare complication of ulcerative colitis (UC) regardless of surgical history of rectum. Various surgical treatment modalities for the closure of rectovaginal fistula have been...

Spontaneous postpartum rupture of an intact uterus: a case report.

Rupture of uterus is an obstetrical complication characterized by a breach in the uterine wall and the overlying serosa. We report an unusual case of spontaneous rupture of an unscarred uterus in a 33...

Investigating the relationship between persistent reflux flow on the first postoperative day and recurrent varicocele in varicocelectomy patients.

The aim of this study was to investigate the presence of persistent reflux flow on the first postoperative day using color Doppler sonography (CDS) in patients who had undergone sub-inguinal varicocel...

Anesthetic considerations on adrenal gland surgery.

Adrenal gland surgery needs a multidisciplinary team including endocrinologist, radiologist, anesthesiologist, and surgeon. The indications for adrenal gland surgery include hormonal secreting and non...

Association between hepatitis C virus and opioid use while in buprenorphine treatment: preliminary findings.

Abstract Background: The prevalence of hepatitis-C-virus (HCV) infections is high among opioid-dependent individuals. Prior research on the simultaneous treatment of both conditions has primarily asse...

Effect of Preoperative Biologic Drugs on Complications and Function After Restorative Proctocolectomy with Primary Ileal Pouch Formation: Systematic Review and Meta-analysis.

Debate exists concerning the presumed risk of postoperative complications in patients with ulcerative colitis (UC) receiving preoperative infliximab (IFX). Meta-analyses are contrasting because of man...

Optimal Antiviral Prophylaxis Against Hepatitis B Reactivation in Patients Receiving Rituximab-Based Chemotherapy for Lymphoma.

Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy: A Randomized Clinical Trial.

Hepatitis B virus (HBV) reactivation is a serious complication for patients with lymphoma treated with rituximab-containing chemotherapies, despite lamivudine prophylaxis treatment. An optimal prophyl...

Assessment of Outcomes of Hepatitis C Treatment-Reply.

Assessment of Outcomes of Hepatitis C Treatment.

News Articles [1272 Associated News Articles listed on BioPortfolio]

Amarna Therapeutics B.V. - Product Pipeline Review - 2014

Recently added to the BioPortfolio report store, Amarna Therapeutics B.V. - Product Pipeline Review - 2014 is a new report from Global Markets Direct published on 2014-12-14. This 23-page report is a...

Lawsuit Alleges Price Gouging by Maker of Hepatitis Drug

Ever since Gilead Sciences began selling its Sovaldi hepatitis C treatment, there has been controversy over the high price. Last week, the transit agency that serves greater Philadelphia filed an unus...

New Report: Hep C's Decades of Drug Research Failures, Successes

The Pharmaceutical Research and Manufacturers of America (PhRMA) released a new report, "Twenty-Five Years of Progress Against Hepatitis C: Setbacks and Stepping Stones," that examines the scientific ...

Drug interaction identified for ondansetron, tramadol

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Ana...

Harvoni Expanded Pool Of Treated Hepatitis C Patients, CVS Data Suggest

A report from the CVS Health Research Institute says Harvoni produced 2.5 times more prescriptions the first eight weeks post-launch than Sovaldi yielded in its first eight weeks, but Sovaldi scripts ...

Preventing Hepatitis C Patients From Being Lost in the Healthcare System

A new study shows that many patients infected with the hepatitis C virus (HCV) are lost during different stages of healthcare to manage the disease. This real-life' view of the HCV patient care contin...

Is the HCV Market Worth Additional Investment?

Over the past year, two products have significantly disrupted the hepatitis C (HCV) market. The breakthrough single and combination treatments from Gilead Sciences Inc. include Sovaldi® (sofosbuvir) ...

BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team

One of the nation’s leading specialty pharmacies, BioPlus, bolsters its team of Regional Pharmaceutical Care Liaisons to better serve as clinical consultants in supporting prescriber offices and pat...

ABIVAX, a Privileged Partner of the Cuban Life Science Industry, Welcomes Initiative to Renew Relations Between the USA and Cuba

PARIS, December 18, 2014 /PRNewswire/ -- ABIVAX, a leading clinical stage biotech company developing and commercialising anti-viral compounds and human vaccines, is pleased to see the new initiative ...

Preventing hepatitis C patients from being lost in the health-care system

A new study shows that many patients infected with the hepatitis C virus (HCV) are lost during different stages of health care to manage the disease. This real-life' view of the HCV patient care conti...

Events [0 Results]

None

Companies [27 Associated Companies listed on BioPortfolio]

Primrose Healthcare

Primrose Healthcare is dedicated to leading the healthcare industry in delivering the most advanced technology and evidence-based care protocols available for the optimized treatm...

Vaxart, Inc.

Vaxart is a privately owned company developing oral recombinant vaccines based on its proprietary delivery platform. The Vaxart platform is suitable to deliver any protein vaccine...

Advanced Biological Laboratories

Advanced Biological Laboratories (ABL), S.A., is a Medical Data Technology company founded in 2000 as a spin-off from CRP-Santé Luxembourg. ABL took control of TherapyEdge, Inc...

Ichor Medical Systems, Inc.

Ichor Medical Systems’ TriGrid™ Delivery System (TriGrid) is the first integrated and fully automated device for electroporation-mediated DNA administration in humans. I...

Transgene SA

Transgene (NYSE-Euronext: TNG), a member of the Institut Mérieux Group, is a biopharmaceutical company. It creates, develops and manufactures targeted immunotherapeutics for th...

AbbVie

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. AbbVie combines the focus and passion of a leading-edge biotech with the exp...

Okairos

Okairos is a clinical-stage biopharmaceutical company, developing genetic vaccines for major infectious diseases - including malaria, hepatitis C, influenza, respiratory syncytial...

Profectus BioSciences, Inc.

Profectus BioSciences, Inc. is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases with a goal of reducing morbidity and mo...

Viropro

Viropro Inc. (“Viropro”) operates through Viropro International Inc., a Canadian company with its Head Office in Montreal. Viropro International Inc. is specialized in the technology transfer, fo...

Enanta Pharmaceuticals, Inc.

Enanta Phatmaceuticals ARE A RESEARCH AND DEVELOPMENT-FOCUSED BIOTECHNOLOGY COMPANY that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in t...

Clinical Trials [1907 Associated Clinical Trials listed on BioPortfolio]

Lidocaine With Epinephrine vs. Bupivacaine With Epinephrine as Local Anesthetic Agents in Wide-awake Hand Surgery

This study is focused on comparing patients' pain scores on a visual analogue scale (VAS) and the difference in analgesics use post-operatively (with the same prescription defining only th...

Dexamethasone and Respiratory Function After Mastectomy

Preoperative dexamethasone reduces symptoms after different surgical procedures including mastectomy in breast cancer, but the effect in the postoperative respiratory function remains unkn...

CRAGS (Coronary aRtery diseAse in younG adultS)

Young patients requiring myocardial revascularization are generally considered at low operative risk, but data on their immediate and late outcome are scarce. The decision-making process i...

An Observational Study To Assess Liver Fibrosis Stages in Patients With Chronic Hepatitis C Infection

This multi-center, prospective observational study will evaluate the correlation of liver biopsy and transient elastography in liver fibrosis assessment in pati ents with chronic hepatitis...

An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C

This prospective, multicenter, observational cohort study will evaluate the effi cacy and safety of peginterferon alfa (e.g. Pegasys) plus ribavirin and treatmen t regimens containing dire...

Acetylcholinesterase in Postoperative Delirium

The level of acetylcholinesterase is suspected to correlate with postoperative delirium. The investigators therefore score patients once preoperatively and twice postoperatively with the g...

PAIN - Postoperative Analgesia INvestigation

The purpose of this study is to assess the efficacy of the intraoperative injection of prolonged acting (liposomal) bupivacaine in postoperative pain control after truncal surgical incisio...

Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs

Define the patients who lost HBsAg, studying the loss predictive factors and if there was suspension of treatment, study the evolution after that

REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Ther

This 4 arm study is designed for patients with CHC who have not responded to peg interferon alfa-2b (12KD)/ribavirin combination therapy. In these patients, the effects of lengthening the ...

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues

This observational study will evaluate the efficacy and safety of Pegasys (pegin terferon alfa-2a) in patients with chronic hepatitis B who have failed antiviral treatment with nucleoside ...

Medical and Biotech [MESH] Definitions

INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D).

A family of hepatotropic DNA viruses which contains double-stranded DNA genomes and causes hepatitis in humans and animals. There are two genera: AVIHEPADNAVIRUS and ORTHOHEPADNAVIRUS. Hepadnaviruses include HEPATITIS B VIRUS, duck hepatitis B virus (HEPATITIS B VIRUS, DUCK), heron hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis B virus (HEPATITIS B VIRUS, WOODCHUCK).

A species in the genus HEPATOVIRUS containing one serotype and two strains: HUMAN HEPATITIS A VIRUS and Simian hepatitis A virus causing hepatitis in humans (HEPATITIS A) and primates, respectively.

INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.

INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.

Search BioPortfolio:
Loading
Advertisement
Advertisement
review and buy Postoperative hepatitis market research data and corporate reports here

Channels Quicklinks